Skip to content
10-Q

Quarterly Report

CHINA JO-JO DRUGSTORES, INC.

0001213900-21-008980

← back to feed
Filed
Feb 12, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Feb 10, 2021 41.75M sh
Shares Diluted Q3 2021 · Dec 31, 2020 41.34M sh
Shares Diluted Q3 2021 · Dec 31, 2020 40.46M sh
Shares Diluted Q3 2021 · Dec 31, 2019 32.94M sh
Shares Diluted Q3 2021 · Dec 31, 2019 32.78M sh
Capex Q3 2021 · Dec 31, 2020 $41.57K
Capex Q3 2021 · Dec 31, 2019 $561.68K
Operating Cash Flow Q3 2021 · Dec 31, 2020 −$12.45M
Operating Cash Flow Q3 2021 · Dec 31, 2019 −$11.27M
Long Term Debt Q3 2021 · Dec 31, 2020 $2.59M
Long Term Debt Q3 2021 · Mar 31, 2020 $4.12M
Short Term Debt Q3 2021 · Dec 31, 2020 $2.3M
Short Term Debt Q3 2021 · Mar 31, 2020 $1.41M
Cash And Equivalents Q3 2021 · Dec 31, 2020 $12.12M
Cash And Equivalents Q3 2021 · Mar 31, 2020 $16.18M
Stockholders Equity Q3 2021 · Dec 31, 2020 $28.12M
Stockholders Equity Q3 2021 · Mar 31, 2020 $20.59M
Current Liabilities Q3 2021 · Dec 31, 2020 $55.88M
Current Liabilities Q3 2021 · Mar 31, 2020 $57.44M
Total Liabilities Q3 2021 · Dec 31, 2020 $76.47M
Total Liabilities Q3 2021 · Mar 31, 2020 $80.74M
Current Assets Q3 2021 · Dec 31, 2020 $63.09M
Current Assets Q3 2021 · Mar 31, 2020 $60.99M
Total Assets Q3 2021 · Dec 31, 2020 $102.56M
Total Assets Q3 2021 · Mar 31, 2020 $99.52M
Eps Diluted Q3 2021 · Dec 31, 2020 −$0.15
Eps Diluted Q3 2021 · Dec 31, 2020 −$0.20
Eps Diluted Q3 2021 · Dec 31, 2019 $0.02
Eps Diluted Q3 2021 · Dec 31, 2019 −$0.09
Eps Basic Q3 2021 · Dec 31, 2020 −$0.15
Eps Basic Q3 2021 · Dec 31, 2020 −$0.20
Eps Basic Q3 2021 · Dec 31, 2019 $0.02
Eps Basic Q3 2021 · Dec 31, 2019 −$0.09
Sga Expense Q3 2021 · Dec 31, 2020 $6.19M
Sga Expense Q3 2021 · Dec 31, 2020 $10.37M
Sga Expense Q3 2021 · Dec 31, 2019 $1.05M
Sga Expense Q3 2021 · Dec 31, 2019 $5.73M
Net Income Q3 2021 · Dec 31, 2020 −$6.26M
Net Income Q3 2021 · Dec 31, 2020 −$7.98M
Net Income Q3 2021 · Dec 31, 2019 $531.78K
Net Income Q3 2021 · Dec 31, 2019 −$2.83M
Operating Income Q3 2021 · Dec 31, 2020 −$6.37M
Operating Income Q3 2021 · Dec 31, 2020 −$8.3M
Operating Income Q3 2021 · Dec 31, 2019 $552.91K
Operating Income Q3 2021 · Dec 31, 2019 −$3.82M
Gross Profit Q3 2021 · Dec 31, 2020 $8.09M
Gross Profit Q3 2021 · Dec 31, 2020 $23.08M
Gross Profit Q3 2021 · Dec 31, 2019 $7.28M
Gross Profit Q3 2021 · Dec 31, 2019 $20.04M
Cost Of Revenue Q3 2021 · Dec 31, 2020 $27.45M
Cost Of Revenue Q3 2021 · Dec 31, 2020 $74.36M
Cost Of Revenue Q3 2021 · Dec 31, 2019 $26.08M
Cost Of Revenue Q3 2021 · Dec 31, 2019 $66.96M
Revenue Q3 2021 · Dec 31, 2020 $35.54M
Revenue Q3 2021 · Dec 31, 2020 $97.44M
Revenue Q3 2021 · Dec 31, 2019 $33.36M
Revenue Q3 2021 · Dec 31, 2019 $87M